ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 978

$390K Total Retail Price of All Prescriptions

Rank: 80 out of 978

261 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 261 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 261 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,506 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 377 313 1 1
SIMVASTATIN 282 235 2 2
METOPROLOL TARTRATE 265 231 3 10
WARFARIN SODIUM 230 215 4 11
OMEPRAZOLE 229 164 5 3
LEVOTHYROXINE SODIUM 214 193 6 4
AMLODIPINE BESYLATE 214 200 6 6
CITALOPRAM HBR 206 194 8 14
FUROSEMIDE 196 181 9 9
DONEPEZIL HCL 193 185 10 26
ATENOLOL 162 133 11 8
NAMENDA 161 152 12 45
HYDROCHLOROTHIAZIDE 146 129 13 5
METOPROLOL SUCCINATE 145 145 14 13
MIRTAZAPINE 136 136 15 31
HYDROCODONE-ACETAMINOPHEN 134 103 S3 16 17
DOXAZOSIN MESYLATE 118 109 17 90
ATORVASTATIN CALCIUM 94 82 18 12
METFORMIN HCL 89 76 19 7
ALENDRONATE SODIUM 81 68 20 20
TRAMADOL HCL 79 60 21 24
LOVASTATIN 79 79 21 29
TRAZODONE HCL 76 59 23 18
POTASSIUM CHLORIDE 72 72 24 41
FLUOXETINE HCL 72 45 24 42
DIGOXIN 68 68 26 54
PAROXETINE HCL 68 59 26 52
METFORMIN HCL ER 67 55 28 48
SERTRALINE HCL 67 55 28 21
DIVALPROEX SODIUM 64 63 30 56
ALLOPURINOL 61 59 31 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 55 32 36
LOSARTAN POTASSIUM 57 44 32 22
PREDNISONE 55 49 34 47
ZOLPIDEM TARTRATE 53 36 35 32
CARBIDOPA-LEVODOPA 52 52 36 81
LANTUS 50 40 37 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.